BioSpace News Archive

A new report from RealSelf, the leading online resource to learn about aesthetic procedures and connect with the doctors who provide them, reveals more men are researching nonsurgical cosmetic treatments in 2019, with interest up six percent compared to 2018

CredSimple, the leading cloud-based healthcare credential verification organization, today announced the closing of a $14 million Series B financing

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the JMP Securities Life Sciences Conference on Wednesday, June 19, 2019 at 2:30 p.m. E.T. in New York

Results to be Presented During a Late-Breaking Oral Session at the Annual European Congress of Rheumatology (EULAR 2019)

The Consortium now includes 15 institutions and is focused on preclinical research, clinical implementation, and advocacy efforts for FLASH Therapy.

Shareholders Urged to Vote Their GREEN Proxy or GREEN VIF to Strengthen Board with Three New, Highly Qualified Independent Nominees

Centene Corporation (NYSE: CNC) (“Centene”) and WellCare Health Plans, Inc. (NYSE: WCG) (“WellCare”) recommends that Centene and WellCare stockholders vote “FOR” all transaction-related proposals at the respective special meetings of stockholders regarding Centene’s pending acquisition of WellCare.

IndraSoft, a leading technology consulting services firm, today announced that the U.S. Army Medical Materiel Agency’s (USAMMA) Distribution Operations Center has received a FedHealthIT Innovation Award for its exceptional initiative on using blockchain technology to track vaccine supply chain.

“We are urging an oil or gas field production worker with confirmed mesothelioma anywhere in the United States or their family members to call us anytime at 800-714-0303 so we can make certain they have on the spot access to attorney Erik Karst the founding partner of the law firm of Karst von Oiste and one of the nation’s top lawyers for oil/gas field workers with mesothelioma.

Dr. Shaw is a highly respected oncologist and recognized leader in translational medicine and the development of targeted cancer therapies.